Click on a filter below to refine your search. Remove a filter to broaden your search.
Homebound status linked to increased odds of ED visit, inpatient admission, skilled nursing-facility admission, mortality
Medicare spending was higher for adults with a formal clinical diagnosis of dementia versus a positive screening for cognitive impairment.
The percentage of older U.S. decedents with a diagnosis of Alzheimer’s disease and related dementias increased significantly from 2004 to 2017.
The risks for disability and transition to probable dementia increased after an ICU stay for seniors with dual eligibility for Medicare and Medicaid.
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Immediate and lasting reductions were seen in the share of patients receiving hospice care with the Alzheimer’s disease and related dementia code.
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
Major changes to prescribing instructions are rare, especially so soon after approval; it change could curb the drug’s use.
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.